Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate

{ 'indexed': {'date-parts': [[2024, 5, 12]], 'date-time': '2024-05-12T04:25:01Z', 'timestamp': 1715487901421}, 'reference-count': 70, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2021, 11, 1]], 'date-time': '2021-11-01T00:00:00Z', 'timestamp': 1635724800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 11]]}, 'DOI': '10.1016/j.tmaid.2021.102163', 'type': 'journal-article', 'created': {'date-parts': [[2021, 9, 14]], 'date-time': '2021-09-14T15:50:41Z', 'timestamp': 1631634641000}, 'page': '102163', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 6, 'title': 'Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and ' 'case fatality rate', 'prefix': '10.1016', 'volume': '44', 'author': [ {'given': 'Roberto Alfonso', 'family': 'Accinelli', 'sequence': 'first', 'affiliation': []}, { 'given': 'Grisel Jesús', 'family': 'Ynga-Meléndez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan Alonso', 'family': 'León-Abarca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lidia Marianella', 'family': 'López', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Juan Carlos', 'family': 'Madrid-Cisneros', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Juan Diego', 'family': 'Mendoza-Saldaña', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.tmaid.2021.102163_bib1', 'doi-asserted-by': 'crossref', 'DOI': '10.2174/1389450122666210215112150', 'article-title': 'Small-molecule antiviral agents in ongoing clinical trials for COVID-19', 'author': 'Apaydın', 'year': '2021', 'journal-title': 'Curr Drug Targets'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib2', 'doi-asserted-by': 'crossref', 'first-page': '202', 'DOI': '10.21037/jtd-20-2022', 'article-title': 'Hydroxychloroquine and chloroquine for treatment of coronavirus disease ' '19 (COVID-19): a systematic review and meta-analysis of randomized and ' 'non-randomized controlled trials', 'volume': '13', 'author': 'Ebina-Shibuya', 'year': '2021', 'journal-title': 'J Thorac Dis'}, { 'issue': '4', 'key': '10.1016/j.tmaid.2021.102163_bib3', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofaa130', 'article-title': 'Review: hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 ' '(COVID-19)', 'volume': '7', 'author': 'Pastick', 'year': '2020', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '10.1016/j.tmaid.2021.102163_bib4', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fphar.2020.597985', 'article-title': 'Hydroxychloroquine in COVID-19 patients: pros and cons', 'volume': '11', 'author': 'Younis', 'year': '2020', 'journal-title': 'Front Pharmacol'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib5', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106078', 'article-title': 'A pharmacological perspective of chloroquine in SARS-CoV-2 infection: ' 'an old drug for the fight against a new coronavirus?', 'volume': '56', 'author': 'Oscanoa', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib6', 'doi-asserted-by': 'crossref', 'first-page': '959', 'DOI': '10.1093/jac/dkr090', 'article-title': 'Early versus late oseltamivir treatment in severely ill patients with ' '2009 pandemic influenza A (H1N1): speed is life', 'volume': '66', 'author': 'Kumar', 'year': '2011', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib7', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.3947/ic.2020.52.3.396', 'article-title': 'Early hydroxychloroquine administration for rapid severe acute ' 'respiratory syndrome coronavirus 2 eradication', 'volume': '52', 'author': 'Hong', 'year': '2020', 'journal-title': 'Infect Chemother'}, { 'issue': '7', 'key': '10.1016/j.tmaid.2021.102163_bib8', 'doi-asserted-by': 'crossref', 'first-page': '2090', 'DOI': '10.1111/all.14768', 'article-title': 'Sputum TNF markers are increased in neutrophilic and severe asthma and ' 'are reduced by azithromycin treatment', 'volume': '76', 'author': 'Niessen', 'year': '2021', 'journal-title': 'Allergy'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib9', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib10', 'doi-asserted-by': 'crossref', 'first-page': '355', 'DOI': '10.1016/0042-6822(66)90046-8', 'article-title': 'Effect of chloroquine on lysosomes and on growth of mouse hepatitis ' 'virus (MHV-3)', 'volume': '28', 'author': 'Mallucci', 'year': '1966', 'journal-title': 'Virology'}, { 'issue': '7', 'key': '10.1016/j.tmaid.2021.102163_bib11', 'doi-asserted-by': 'crossref', 'DOI': '10.1073/pnas.75.7.3327', 'article-title': 'Fluorescence probe measurement of the intralysosomal pH in living cells ' 'and the perturbation of pH by various agents', 'volume': '75', 'author': 'Ohkuma', 'year': '1978', 'journal-title': 'Proc Natl Acad Sci Unit States Am'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib12', 'doi-asserted-by': 'crossref', 'first-page': '346', 'DOI': '10.1016/0014-4800(87)90018-9', 'article-title': 'Comparison of different autophagic vacuoles with regard to ' 'ultrastructure, enzymatic composition, and degradation ' 'capacity—formation of crinosomes', 'volume': '47', 'author': 'Glaumann', 'year': '1987', 'journal-title': 'Exp Mol Pathol'}, { 'issue': '11', 'key': '10.1016/j.tmaid.2021.102163_bib13', 'doi-asserted-by': 'crossref', 'first-page': '722', 'DOI': '10.1016/S1473-3099(03)00806-5', 'article-title': "Effects of chloroquine on viral infections: an old drug against today's " 'diseases?', 'volume': '3', 'author': 'Savarino', 'year': '2003', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '6965', 'key': '10.1016/j.tmaid.2021.102163_bib14', 'doi-asserted-by': 'crossref', 'first-page': '450', 'DOI': '10.1038/nature02145', 'article-title': 'Angiotensin-converting enzyme 2 is a functional receptor for the SARS ' 'coronavirus', 'volume': '426', 'author': 'Li', 'year': '2003', 'journal-title': 'Nature'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib15', 'doi-asserted-by': 'crossref', 'first-page': '264', 'DOI': '10.1016/j.bbrc.2004.08.085', 'article-title': 'In vitro inhibition of severe acute respiratory syndrome coronavirus by ' 'chloroquine', 'volume': '323', 'author': 'Keyaerts', 'year': '2004', 'journal-title': 'Biochem Biophys Res Commun'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib16', 'doi-asserted-by': 'crossref', 'DOI': '10.1186/1743-422X-2-69', 'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and ' 'spread', 'volume': '2', 'author': 'Vincent', 'year': '2005', 'journal-title': 'Virol J'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib17', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib18', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105960', 'article-title': 'Structural and molecular modelling studies reveal a new mechanism of ' 'action of chloroquine and hydroxychloroquine against SARS-CoV-2 ' 'infection', 'volume': '55', 'author': 'Fantini', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib19', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1038/s41421-019-0132-8', 'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is ' 'effective in inhibiting SARS-CoV-2 infection in vitro', 'volume': '6', 'author': 'Liu', 'year': '2020', 'journal-title': 'Cell Discov'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib20', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41598-020-70143-6', 'article-title': 'In vitro screening of a FDA approved chemical library reveals potential ' 'inhibitors of SARS-CoV-2 replication', 'volume': '10', 'author': 'Touret', 'year': '2020', 'journal-title': 'Sci Rep'}, { 'issue': '4', 'key': '10.1016/j.tmaid.2021.102163_bib21', 'doi-asserted-by': 'crossref', 'first-page': '775', 'DOI': '10.1002/cpt.1909', 'article-title': 'Prioritization of anti‐SARS‐Cov‐2 drug repurposing opportunities based ' 'on plasma and target site concentrations derived from their established ' 'human pharmacokinetics', 'volume': '108', 'author': 'Arshad', 'year': '2020', 'journal-title': 'Clin Pharmacol Ther'}, { 'issue': '2', 'key': '10.1016/j.tmaid.2021.102163_bib22', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106020', 'article-title': 'Synergistic antiviral effect of hydroxychloroquine and azithromycin in ' 'combination against SARS-CoV-2: what molecular dynamics studies of ' 'virus-host interactions reveal', 'volume': '56', 'author': 'Fantini', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.tmaid.2021.102163_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.micpath.2020.104228', 'article-title': 'In vitro testing of combined hydroxychloroquine and azithromycin on ' 'SARS-CoV-2 shows synergistic effect', 'volume': '145', 'author': 'Andreani', 'year': '2020', 'journal-title': 'Microb Pathog'}, { 'issue': '7816', 'key': '10.1016/j.tmaid.2021.102163_bib24', 'doi-asserted-by': 'crossref', 'first-page': '459', 'DOI': '10.1038/s41586-020-2286-9', 'article-title': 'A SARS-CoV-2 protein interaction map reveals targets for drug ' 'repurposing', 'volume': '583', 'author': 'Gordon', 'year': '2020', 'journal-title': 'Nature'}, { 'issue': '9', 'key': '10.1016/j.tmaid.2021.102163_bib25', 'doi-asserted-by': 'crossref', 'first-page': '1269', 'DOI': '10.1517/13543776.16.9.1269', 'article-title': 'Potential therapies for coronaviruses', 'volume': '16', 'author': 'Savarino', 'year': '2006', 'journal-title': 'Expert Opin Ther Pat'}, {'key': '10.1016/j.tmaid.2021.102163_bib26', 'author': 'de Salud del Perú'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib27', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1016/j.amjmed.2020.07.003', 'article-title': 'Pathophysiological basis and rationale for early outpatient treatment ' 'of SARS-CoV-2 (COVID-19) infection', 'volume': '134', 'author': 'McCullough', 'year': '2021', 'journal-title': 'Am J Med'}, { 'key': '10.1016/j.tmaid.2021.102163_bib28', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101738', 'article-title': 'Early treatment of COVID-19 patients with hydroxychloroquine and ' 'azithromycin: a retrospective analysis of 1061 cases in Marseille, ' 'France', 'volume': '35', 'author': 'Million', 'year': '2020', 'journal-title': 'Trav Med Infect Dis'}, { 'key': '10.1016/j.tmaid.2021.102163_bib29', 'series-title': 'COVID-19 coronavirus pandemic [Internet]', 'year': '2020'}, { 'key': '10.1016/j.tmaid.2021.102163_bib30', 'series-title': 'Sala situacional COVID-19 Perú [Internet]', 'author': 'de Salud del Perú', 'year': '2020'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib31', 'doi-asserted-by': 'crossref', 'first-page': '2202', 'DOI': '10.1172/JCI137647', 'article-title': 'SARS-CoV-2: a storm is raging', 'volume': '130', 'author': 'Pedersen', 'year': '2020', 'journal-title': 'J Clin Invest'}, { 'key': '10.1016/j.tmaid.2021.102163_bib32', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.nmni.2020.100776', 'article-title': 'Hydroxychloroquine is effective, and consistently so when provided ' 'early, for COVID-19: a systematic review', 'volume': '38', 'author': 'Prodromos', 'year': '2020', 'journal-title': 'New Microbes New Infect'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib33', 'doi-asserted-by': 'crossref', 'first-page': '1150', 'DOI': '10.1093/jac/dkr089', 'article-title': 'Benefit of early treatment with oseltamivir in hospitalized patients ' 'with documented 2009 influenza A (H1N1): retrospective cohort study', 'volume': '66', 'author': 'Hiba', 'year': '2011', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib34', 'doi-asserted-by': 'crossref', 'first-page': '1140', 'DOI': '10.1093/jac/dkq511', 'article-title': 'Impact of early oseltamivir treatment on outcome in critically ill ' 'patients with 2009 pandemic influenza A', 'volume': '66', 'author': 'Rodríguez', 'year': '2011', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib35', 'doi-asserted-by': 'crossref', 'first-page': '257', 'DOI': '10.1503/cmaj.091884', 'article-title': 'Correlates of severe disease in patients with 2009 pandemic influenza ' '(H1N1) virus infection', 'volume': '182', 'author': 'Zarychanski', 'year': '2010', 'journal-title': 'Can Med Assoc J'}, { 'key': '10.1016/j.tmaid.2021.102163_bib36', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.eclinm.2020.100591', 'volume': '28', 'author': 'Guisado-Vasco', 'year': '2020', 'journal-title': 'EClinicalMedicine'}, { 'issue': '6', 'key': '10.1016/j.tmaid.2021.102163_bib37', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106214', 'article-title': 'COVID-19 outpatients – early risk-stratified treatment with zinc plus ' 'low dose hydroxychloroquine and azithromycin: a retrospective case ' 'series study', 'volume': '56', 'author': 'Derwand', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib38', 'doi-asserted-by': 'crossref', 'first-page': '601', 'DOI': '10.1007/s41999-020-00432-w', 'article-title': 'CO VID-19 mortality risk factors in older people in a long-term care ' 'center', 'volume': '12', 'author': 'Heras', 'year': '2021', 'journal-title': 'Eur Geriatr Med'}, { 'key': '10.1016/j.tmaid.2021.102163_bib39', 'doi-asserted-by': 'crossref', 'unstructured': 'Chen L., Zhang Z.Y., Fu J.G., Feng Z.P., Zhang S.Z., Han Q.Y., et al. ' 'Efficacy and safety of chloroquine or hydroxychloroquine in moderate ' 'type of COVID-19: a prospective open-label randomized controlled study. ' 'MedRxiv 2020.06.19.20136093. doi:10.1101/2020.06.19.20136093.', 'DOI': '10.1101/2020.06.19.20136093'}, { 'issue': 'April', 'key': '10.1016/j.tmaid.2021.102163_bib40', 'doi-asserted-by': 'crossref', 'first-page': '45', 'DOI': '10.9734/ajmah/2020/v18i730224', 'article-title': 'Azithromycin and hydroxychloroquine accelerate recovery of outpatients ' 'with mild/moderate', 'volume': '18', 'author': 'Guérin', 'year': '2020', 'journal-title': 'Asian J Med Heal'}, { 'issue': '6', 'key': '10.1016/j.tmaid.2021.102163_bib41', 'doi-asserted-by': 'crossref', 'first-page': '408', 'DOI': '10.5582/bst.2020.03340', 'article-title': 'Efficacy of early hydroxychloroquine treatment in preventing COVID-19 ' 'pneumonia aggravation, the experience from Shanghai, China', 'volume': '14', 'author': 'Su', 'year': '2020', 'journal-title': 'Biosci trends'}, { 'key': '10.1016/j.tmaid.2021.102163_bib42', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2021.107636', 'article-title': 'Clinical outcomes of patients with mild COVID-19 following treatment ' 'with hydroxychloroquine in an outpatient setting', 'volume': '96', 'author': 'Mokhtari', 'year': '2021', 'journal-title': 'Int Immunopharm'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib43', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s12879-021-05773-w', 'article-title': 'Hydroxychloroquine in the treatment of outpatients with mildly ' 'symptomatic COVID-19: a multi-center observational study', 'volume': '21', 'author': 'Ip', 'year': '2021', 'journal-title': 'BMC Infect Dis'}, { 'key': '10.1016/j.tmaid.2021.102163_bib44', 'article-title': 'Risk of hospitalization for Covid-19 outpatients treated with various ' 'drug regimens in Brazil: comparative analysis', 'volume': '38', 'author': 'Fonseca', 'year': '2020', 'journal-title': 'Trav Med Infect Dis'}, { 'key': '10.1016/j.tmaid.2021.102163_bib45', 'doi-asserted-by': 'crossref', 'unstructured': 'Sulaiman T., Mohana A., Alawdah L., Mahmoud N., Hassanein M., Wani T., ' 'et al. The effect of early hydroxychloroquine-based therapy in COVID-19 ' 'patients in ambulatory care settings: a nationwide prospective cohort ' 'study. medRxiv 2020.09.09.20184143. doi:10.1101/2020.09.09.20184143.', 'DOI': '10.1101/2020.09.09.20184143'}, { 'key': '10.1016/j.tmaid.2021.102163_bib46', 'first-page': '462', 'article-title': 'Therapeutic potential of ivermectin as add on treatment in COVID 19: a ' 'systematic review and meta-analysis: ivermectin in COVID-19: a ' 'meta-analysis', 'volume': '23', 'author': 'Padhy', 'year': '2020', 'journal-title': 'J Pharm Pharmaceut Sci'}, { 'issue': '8', 'key': '10.1016/j.tmaid.2021.102163_bib47', 'doi-asserted-by': 'crossref', 'first-page': '924', 'DOI': '10.1016/S2213-2600(21)00222-8', 'article-title': 'Colchicine for community-treated patients with COVID-19 (COLCORONA): a ' 'phase 3, randomised, double-blinded, adaptive, placebo-controlled, ' 'multicentre trial', 'volume': '9', 'author': 'Tardif', 'year': '2021', 'journal-title': 'Lancet Respir Med'}, { 'issue': '22', 'key': '10.1016/j.tmaid.2021.102163_bib48', 'doi-asserted-by': 'crossref', 'first-page': '2292', 'DOI': '10.1001/jama.2020.22760', 'article-title': 'Fluvoxamine vs placebo and clinical deterioration in outpatients with ' 'symptomatic COVID-19: a randomized clinical trial', 'volume': '324', 'author': 'Lenze', 'year': '2020', 'journal-title': 'J Am Med Assoc'}, { 'issue': '3', 'key': '10.1016/j.tmaid.2021.102163_bib49', 'doi-asserted-by': 'crossref', 'first-page': 'E562', 'DOI': '10.1152/ajpendo.00295.2020', 'article-title': 'Sex-derived attributes contributing to SARS-CoV-2 mortality', 'volume': '319', 'author': 'Chanana', 'year': '2020', 'journal-title': 'Am J Physiol Endocrinol Metab'}, { 'issue': '22', 'key': '10.1016/j.tmaid.2021.102163_bib50', 'doi-asserted-by': 'crossref', 'first-page': '5918', 'DOI': '10.1182/blood-2011-03-340281', 'article-title': 'Sex differences in resident immune cell phenotype underlie more ' 'efficient acute inflammatory responses in female mice', 'volume': '118', 'author': 'Scotland', 'year': '2011', 'journal-title': 'Blood'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib51', 'doi-asserted-by': 'crossref', 'first-page': '1782', 'DOI': '10.4049/jimmunol.1601166', 'article-title': 'Sex drives dimorphic immune responses to viral infections', 'volume': '198', 'author': 'Ghosh', 'year': '2017', 'journal-title': 'J Immunol'}, { 'key': '10.1016/j.tmaid.2021.102163_bib52', 'article-title': 'Sex differences in severity and mortality among patients with COVID-19: ' 'evidence from pooled literature analysis and insights from integrated ' 'bioinformatic analysis', 'author': 'Wei', 'year': '2003', 'journal-title': 'arXiv preprint arXiv'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib53', 'doi-asserted-by': 'crossref', 'first-page': '161', 'DOI': '10.1161/01.CIR.91.1.161', 'article-title': 'Myocardial fibrosis and stiffness with hypertrophy and heart failure in ' 'the spontaneously hypertensive rat', 'volume': '91', 'author': 'Conrad', 'year': '1995', 'journal-title': 'Circulation'}, { 'issue': '6', 'key': '10.1016/j.tmaid.2021.102163_bib54', 'doi-asserted-by': 'crossref', 'first-page': 'L1280', 'DOI': '10.1152/ajplung.00153.2020', 'article-title': 'Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in ' 'differentiated airway epithelial cells', 'volume': '318', 'author': 'Stelzig', 'year': '2020', 'journal-title': 'Am J Physiol Lung Cell Mol Physiol'}, { 'key': '10.1016/j.tmaid.2021.102163_bib55', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.redox.2020.101615', 'article-title': 'Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative ' 'anti-inflammatory receptor and priming protease of SARS-CoV-2 in human ' 'cells, and identification of putative modulators', 'volume': '36', 'author': 'Gkogkou', 'year': '2020', 'journal-title': 'Redox Biol'}, { 'issue': '17', 'key': '10.1016/j.tmaid.2021.102163_bib56', 'first-page': '4180', 'article-title': 'Prostate-localized and androgen-regulated expression of the ' 'membrane-bound serine protease TMPRSS2', 'volume': '59', 'author': 'Lin', 'year': '1999', 'journal-title': 'Cancer Res'}, { 'issue': '9', 'key': '10.1016/j.tmaid.2021.102163_bib57', 'doi-asserted-by': 'crossref', 'first-page': '825', 'DOI': '10.1007/s00011-020-01372-8', 'article-title': 'The possible pathophysiology mechanism of cytokine storm in elderly ' 'adults with COVID-19 infection: the contribution of “inflame-aging”', 'volume': '69', 'author': 'Meftahi', 'year': '2020', 'journal-title': 'Inflamm Res'}, { 'key': '10.1016/j.tmaid.2021.102163_bib58', 'doi-asserted-by': 'crossref', 'first-page': '91', 'DOI': '10.1016/j.ijid.2020.03.017', 'article-title': 'Prevalence of comorbidities and its effects in patients infected with ' 'SARS-CoV-2: a systematic review and meta-analysis', 'volume': '94', 'author': 'Yang', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'issue': '16', 'key': '10.1016/j.tmaid.2021.102163_bib59', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms21165793', 'article-title': 'Obesity and COVID-19: molecular mechanisms linking both pandemics', 'volume': '21', 'author': 'Ritter', 'year': '2020', 'journal-title': 'Int J Mol Sci'}, { 'issue': '5', 'key': '10.1016/j.tmaid.2021.102163_bib60', 'doi-asserted-by': 'crossref', 'first-page': '1017', 'DOI': '10.1016/j.dsx.2020.06.064', 'article-title': 'Coronavirus disease (COVID-19): a systematic review and meta-analysis ' 'to evaluate the impact of various comorbidities on serious events', 'volume': '14', 'author': 'Nandy', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.tmaid.2021.102163_bib61', 'doi-asserted-by': 'crossref', 'first-page': '1991', 'DOI': '10.3389/fimmu.2020.01991', 'article-title': 'The impact of pre-existing comorbidities and therapeutic interventions ' 'on COVID-19', 'volume': '11', 'author': 'Callender', 'year': '2020', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/j.tmaid.2021.102163_bib62', 'series-title': 'Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment', 'year': '2020'}, { 'key': '10.1016/j.tmaid.2021.102163_bib63', 'series-title': 'Directiva Sanitaria N° 135-MINSA/CDC-2021. Directiva sanitaria para la ' 'vigilancia epidemiológica de la enfermedad por coronavirus (COVID-19) en ' 'el Perú', 'author': 'de Salud del Perú', 'year': '2020'}, { 'issue': '1', 'key': '10.1016/j.tmaid.2021.102163_bib64', 'doi-asserted-by': 'crossref', 'first-page': '640', 'DOI': '10.1186/s12879-020-05371-2', 'article-title': 'Epidemiologic, clinical, and laboratory findings of the COVID-19 in the ' 'current pandemic: systematic review and meta-analysis', 'volume': '20', 'author': 'Xie', 'year': '2020', 'journal-title': 'BMC Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.tmaid.2021.102163_bib65', 'doi-asserted-by': 'crossref', 'first-page': 'E115', 'DOI': '10.1148/radiol.2020200432', 'article-title': 'Sensitivity of chest CT for COVID-19: Comparison to RT-PCR', 'volume': '296', 'author': 'Fang', 'year': '2020', 'journal-title': 'Radiology'}, { 'issue': '19', 'key': '10.1016/j.tmaid.2021.102163_bib66', 'first-page': '10208', 'article-title': 'Seropositivity rate and diagnostic accuracy of serological tests in ' '2019-nCoV cases: a pooled analysis of individual studies', 'volume': '24', 'author': 'Guo', 'year': '2020', 'journal-title': 'Eur Rev Med Pharmacol Sci'}, { 'key': '10.1016/j.tmaid.2021.102163_bib67', 'series-title': 'Prevención, Diagnóstico y Tratamiento de personas afectadas por COVID-19 ' 'en el Perú. Resolución Ministerial N° 270-2020-MINSA', 'author': 'de Salud del Perú', 'year': '2020'}, { 'key': '10.1016/j.tmaid.2021.102163_bib68', 'series-title': 'COMUNICADO CONJUTNO SPMI, SPN, SOPEMI, SOPEHE, SPEIT SOBRE USO DE ' 'MEDICAMENTOS PARA EL COVID-19 A LA OPINIÓN PÚBLICA', 'year': '2020'}, { 'issue': '2', 'key': '10.1016/j.tmaid.2021.102163_bib69', 'first-page': '231', 'article-title': 'Sobre las recomendaciones del Ministerio de Salud para el tratamiento ' 'farmacológico de la COVID-19 en el Perú', 'volume': '37', 'author': 'Chirinos', 'year': '2020', 'journal-title': 'Acta Méd Peru'}, { 'key': '10.1016/j.tmaid.2021.102163_bib70', 'series-title': 'El manejo ambulatorio del COVID-19. Diario El Comercio', 'author': 'Huerta', 'year': '2020'}], 'container-title': 'Travel Medicine and Infectious Disease', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1477893921002040?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1477893921002040?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 4, 3]], 'date-time': '2023-04-03T11:53:55Z', 'timestamp': 1680522835000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1477893921002040'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 11]]}, 'references-count': 70, 'alternative-id': ['S1477893921002040'], 'URL': 'http://dx.doi.org/10.1016/j.tmaid.2021.102163', 'relation': {}, 'ISSN': ['1477-8939'], 'subject': [], 'container-title-short': 'Travel Medicine and Infectious Disease', 'published': {'date-parts': [[2021, 11]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Hydroxychloroquine / azithromycin in COVID-19: The association between time to ' 'treatment and case fatality rate', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Travel Medicine and Infectious Disease', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.tmaid.2021.102163', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2021 Published by Elsevier Ltd.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '102163'}